Pfizer CEO Defends Celebrex, Won't Recall It
98811
Pfizer Chief Executive Hank  McKinnell said on Sunday doctors should be made aware of the  health risks in prescribing Celebrex to their patients, but the  company does not plan to recall its popular arthritis drug.
213386
NEW YORK - At Merck&#39;s annual analyst meeting, Chief Executive Raymond Gilmartin defended his company&#39;s handling of Vioxx and outlined changes that he says could help restore Merck&#39;s health.
335553
Pfizer Inc. said it has found an increased risk of heart attacks with patients taking its top-selling painkiller Celebrex, a drug that is in the same class as Vioxx, but has no plans to remove it from the market.
384589
The widow and son of a Texas man who was taking a GlaxoSmithKline Plc diabetes drug at the time of his fatal heart attack claims the drugmaker failed to warn about the drug's risks, according to a lawsuit.
119087
Pfizer Inc. says it will immediately pull advertising for its top-selling arthritis pain reliever Celebrex, whose safety was called into question last week after a study found an increased risk of heart attacks in patients taking high dosages of the drug.
257790
Celebrex, a huge-selling painkiller sold by Pfizer, more than tripled the risk of heart attacks, strokes and death among those taking high doses in a national trial, the company said Friday.
538184
A study in a leading medical journal found Pfizer&#39;s Celebrex does not pose the same risk of causing heart attacks as Vioxx, the competing medicine Merck withdrew from the market because of safety concerns.
614958
The head of the U.S. Food and Drug Administration defended the industry fees that help fund drug reviews on Friday, saying the money from manufacturers did not sway decisions in their favor.
481067
Pharmaceutical giant Pfizer Inc. will announce plans for a large-scale clinical trial of the ability of blockbuster drug Celebrex to prevent heart attacks and strokes in patients with cardiovascular disease, the Wall Street Journal reported on Monday.
15542
Pfizer says not to worry, its arthritis pain drug Celebrex won&#39;t go the way of Vioxx. Pfizer says it won&#39;t withdraw Celebrex, its blockbuster arthritis pain medicine, despite Friday&#39;s disclosure
230112
Pfizer Inc. is indefinitely suspending all consumer advertising of its arthritis drug Celebrex, following last week&#39;s revelation of a study that showed high doses caused an increased risk of heart attacks among cancer patients.
143159
Some analysts are betting Pfizer Inc.  PFE.N won't have to withdraw its arthritis drug Celebrex but  they do expect sales to fall after a study of the drug in  cancer patients showed it increased the risk of heart attacks.
422768
Pfizer reaffirmed its commitment today to Celebrex, its blockbuster prescription medication for pain and inflammation from arthritis.
758212
As Pfizer&#39;s (PFE:NYSE - news - research) Celebrex safety hiccup was unfolding Friday, I had a running conversation with a fund manager.
69221
Although advertising will be suspended indefinitely, Pfizer plans to continue marketing Celebrex to doctors.
745709
At a research and development meeting for analysts on Nov. 30, Pfizer (PFE ) stayed on message all day long. Despite questions about possible safety issues with arthritis pain medication Celebrex, patent challenges
681063
U.S. patent officials have initially rejected claims for the basic patent on Pfizer Inc's blockbuster Lipitor cholesterol treatment, although the drug maker said on Monday it remained confident the patent would ultimately be upheld.